Study guide

11.2 Management of Diabetic Ketoacidosis (DKA) & Hyperosmolar Hyperglycemic State (HHS)

Singapore Nursing Board SNB

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Legal Framework & Regulatory Governing of Nursing in Singapore

1.1 Nurses and Midwives Act & SNB Regulatory Powers 1.2 Scope of Professional Nursing Practice & Accountability 1.3 Informed Consent, Confidentiality & PDPA in Healthcare

2 Chapter 2: Ethical Standards & Professional Code of Conduct

2.1 SNB Code for Nurses and Midwives & Ethical Principles 2.2 Patient Rights, Advocacy & End-of-Life Ethical Decision-Making 2.3 Safeguarding Vulnerable Patients & Mandatory Reporting

3 Chapter 3: Holistic Patient Assessment & Nursing Process

3.1 Comprehensive Physical Assessment & Vital Signs Monitoring 3.2 Early Warning Scores & Recognising the Deteriorating Patient 3.3 Nursing Diagnosis, Person-Centred Care Planning & Evaluation

4 Chapter 4: Communication, Documentation & Clinical Safety

4.1 Therapeutic Communication & Interpersonal Care Relationships 4.2 Clinical Documentation Standards & ISBAR Clinical Handover 4.3 Clinical Risk Management, Fall Prevention & Patient Safety Goals

5 Chapter 5: Infection Prevention & Control Standards

5.1 Standard & Transmission-Based Precautions (Infection Control) 5.2 Aseptic Technique, Surgical Hand Antisepsis & Wound Care Asepsis 5.3 Outbreak Management, Multi-Drug Resistant Organisms (MDROs) & Bio-waste

6 Chapter 6: Safe Medication Administration & Clinical Pharmacology

6.1 Rights of Medication Administration & High-Alert Medications 6.2 Dosage Calculations, Unit Conversions & Pediatric/Geriatric Adjustments 6.3 Pharmacokinetics, Adverse Drug Reactions & Poison Management 6.4 Medication Reconciliation, Storage & Controlled Substances Act in SG

7 Chapter 7: Intravenous Therapy, Fluid & Electrolyte Management

7.1 Fluid Balance, Electrolyte Disturbances & ABG Interpretation 7.2 Peripheral & Central Venous Line Access, Care & Complications 7.3 Blood Product Transfusion Standards, Safety & Adverse Reaction Management

8 Chapter 8: Respiratory Care & Oxygenation Management

8.1 Airway Management, Oxygen Therapy & Pulse Oximetry 8.2 Tracheostomy Care, Suctioning & Mechanical Ventilation Nursing 8.3 Nursing Care in Acute Respiratory Distress & Chronic Obstructive Pulmonary Disease

9 Chapter 9: Cardiovascular Nursing & Hemodynamic Monitoring

9.1 Cardiac Assessment, ECG Interpretation & Common Arrhythmias 9.2 Acute Coronary Syndrome, Heart Failure & Hypertensive Crises Nursing 9.3 Shock Classification, Fluid Resuscitation & Hemodynamic Monitoring

10 Chapter 10: Medical-Surgical Nursing: Gastrointestinal & Renal Systems

10.1 Enteral & Parenteral Nutrition Management 10.2 Care of Acute Abdomen, Ostomy Care & Gastrointestinal Bleeding 10.3 Acute Kidney Injury, Chronic Kidney Disease & Dialysis Nursing

11 Chapter 11: Endocrine & Metabolic Nursing Management

11.1 Diabetes Mellitus: Glycemic Control, Insulin Therapy & Complications 11.2 Management of Diabetic Ketoacidosis (DKA) & Hyperosmolar Hyperglycemic State (HHS) 11.3 Thyroid, Adrenal & Pituitary Endocrine Disorders

12 Chapter 12: Neurological Nursing & Musculoskeletal Care

12.1 Neurological Assessment, Glasgow Coma Scale (GCS) & Stroke Care 12.2 Increased Intracranial Pressure (ICP) & Seizure Management 12.3 Musculoskeletal Assessment, Traction, Cast Care & Mobility Promotion

13 Chapter 13: Perioperative & Wound Management

13.1 Preoperative Assessment, Preparation & Informed Consent Verification 13.2 Intraoperative Standards, Surgical Time-Out & Anesthesia Monitoring 13.3 Postoperative Recovery, Pain Management & Wound Healing Staging

14 Chapter 14: Elder Care, Gerontological Nursing & Chronic Disease

14.1 Comprehensive Geriatric Assessment & Frailty Syndromes 14.2 Dementia, Delirium & Depression in Older Adults 14.3 Pressure Injury Prevention, Staging & Advanced Wound Dressings

15 Chapter 15: Mental Health Nursing & Psychosocial Care

15.1 Mental Health Assessment & Therapeutic Nurse-Patient Engagement 15.2 Mood Disorders, Psychosis & Crisis Intervention 15.3 Mental Health Act in Singapore, De-escalation & Patient Safety

16 Chapter 16: Palliative Care & Symptom Management

16.1 Principles of Palliative & End-of-Life Nursing Care 16.2 Pain Assessment, Opioid Titration & Breakthrough Pain Management 16.3 Advance Care Planning (ACP) & Care of the Dying Patient

17 Chapter 17: Interprofessional Collaboration & Care Coordination

17.1 Transdisciplinary Team Dynamics & Multidisciplinary Case Conferences 17.2 Care Coordination, Community Discharge Planning & Continuity of Care 17.3 Conflict Resolution & Interprofessional Communication

18 Chapter 18: Delegation, Supervision & Clinical Leadership

18.1 Principles of Delegation to Enrolled Nurses (ENs) & Ancillary Staff 18.2 Clinical Supervision, Resource Management & Ward Operations 18.3 Quality Improvement, Clinical Audit & Incident Reporting

19 Chapter 19: Evidence-Based Practice, Education & Professional Growth

19.1 Reflective Practice & SNB CPE (Continuing Professional Education) Requirements 19.2 Integrating Evidence-Based Practice (EBP) into Clinical Care 19.3 Clinical Education, Student Preceptorship & Mentorship

11.2 Management of Diabetic Ketoacidosis (DKA) & Hyperosmolar Hyperglycemic State (HHS)

Key Takeaways Explain This Topic AI

DKA presents with hyperglycemia (> 14 mmol/L), metabolic acidosis (pH < 7.30, HCO3 < 18 mEq/L), elevated anion gap, and ketosis, while HHS presents with severe hyperglycemia (> 30 mmol/L), hyperosmolality (> 320 mOsm/kg), extreme fluid deficits (9-12 L), and minimal ketosis.

Initial fluid resuscitation requires 0.9% Normal Saline 1 L/hr, adjusting to 0.45% Saline based on corrected sodium, and adding 5% Dextrose when CBG reaches 14 mmol/L in DKA (or 16.7 mmol/L in HHS) to prevent cerebral edema.

Continuous IV Regular Insulin (0.1 units/kg/hr) must be HELD if serum potassium is < 3.5 mmol/L until potassium is replaced to prevent fatal dysrhythmias.

Transition from IV to subcutaneous insulin requires administering subcutaneous basal insulin 1–2 hours prior to stopping the IV insulin infusion to prevent rebound ketoacidosis.

Neurological observations (GCS) must be performed hourly to detect early signs of cerebral edema (headache, lethargy, bradycardia), treated urgently with IV Mannitol or 3% Hypertonic Saline.

Last updated: July 2026

  • 11.2 Management of Diabetic Ketoacidosis (DKA) & Hyperosmolar Hyperglycemic State (HHS)
  • Pathophysiology & Differential Diagnosis of Hyperglycemic Emergencies

Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycemic State (HHS) are acute, life-threatening metabolic complications of diabetes mellitus requiring rapid recognition, intensive monitoring, and protocolized resuscitation in emergency and high-dependency units across Singapore hospitals.

Pathophysiologic Mechanisms

Diabetic Ketoacidosis (DKA) : Triggered by absolute or relative insulin deficiency combined with counter-regulatory hormone excess (glucagon, catecholamines, cortisol, growth hormone). Unopposed lipolysis leads to the breakdown of adipose tissue into free fatty acids (FFAs). In the liver, FFAs undergo β \beta β -oxidation to form ketone bodies ( β \beta β -hydroxybutyrate and acetoacetate), inducing metabolic acidosis with an elevated anion gap. DKA predominantly affects Type 1 Diabetes Mellitus patients, though it occurs in Type 2 DM under severe physiological stress (infections, myocardial infarction, stroke).

Hyperosmolar Hyperglycemic State (HHS) : Characterized by severe hyperglycemia, hyperosmolality, and profound dehydration in the absence of significant ketoacidosis. HHS typically occurs in older patients with Type 2 DM. Residual endogenous insulin is sufficient to suppress lipolysis and hepatic ketogenesis, preventing severe ketoacidosis, but insufficient to facilitate peripheral glucose uptake. Extreme hyperglycemia leads to massive osmotic diuresis, fluid deficits of 9–12 liters (10–15% of total body weight), hyperosmolality, and progressive neurological impairment.

Comparative Diagnostic Criteria

  • Clinical / Laboratory Parameter Diabetic Ketoacidosis (DKA) Hyperosmolar Hyperglycemic State (HHS)
  • Primary Patient Population Type 1 DM (any age) Type 2 DM (typically elderly)

Precipitating Factors Infection (30-40%), non-adherence, new-onset T1DM Severe infection, pneumonia, UTI, stroke, inadequate fluid access

Capillary / Plasma Glucose > 14.0 mmol/L > 14.0 \text{ mmol/L} > 14.0 mmol/L (usually 14–30 mmol/L) > 30.0 mmol/L > 30.0 \text{ mmol/L} > 30.0 mmol/L (often 35–60+ mmol/L)

Arterial / Venous pH Mild: 7.25–7.30; Moderate: 7.00–7.24; Severe: < 7.00 < 7.00 < 7.00 > 7.30 > 7.30 > 7.30 (normal or mild acidosis)

Serum Bicarbonate ( H C O 3 − HCO_3^- H C O 3 − ​ ) Mild: 15–18 mEq/L; Severe: < 10 mEq/L < 10 \text{ mEq/L} < 10 mEq/L > 18 mEq/L > 18 \text{ mEq/L} > 18 mEq/L

Serum / Urine Ketones Strongly positive ( β \beta β -hydroxybutyrate > 3.0 mmol/L > 3.0 \text{ mmol/L} > 3.0 mmol/L ) Absent or trace

Effective Serum Osmolality Variable ( < 320 mOsm/kg < 320 \text{ mOsm/kg} < 320 mOsm/kg ) Strongly elevated ( > 320 mOsm/kg > 320 \text{ mOsm/kg} > 320 mOsm/kg )

Anion Gap High ( > 12 mEq/L > 12 \text{ mEq/L} > 12 mEq/L ) Variable (usually normal ≤ 12 mEq/L \le 12 \text{ mEq/L} ≤ 12 mEq/L )

Typical Fluid Deficit 100 mL/kg (approx. 5–7 Liters) 100–200 mL/kg (approx. 9–12 Liters)

Clinical Features Kussmaul respiration, acetone breath, abdominal pain Profound lethargy, confusion, focal neuro signs, coma

Fluid Resuscitation & Glucose Management Protocols

The primary therapeutic objective in DKA and HHS is intravascular volume expansion, restoration of renal perfusion, gradual reduction of serum osmolality, and clearance of ketones.

Fluid Resuscitation Sequence

Initial Volume Expansion : Infuse 0.9% Sodium Chloride (Normal Saline) at 1000 mL/hr 1000 \text{ mL/hr} 1000 mL/hr ( 15 – 20 mL/kg/hr 15–20 \text{ mL/kg/hr} 15–20 mL/kg/hr ) during the first hour to restore hemodynamic stability and renal perfusion.

Subsequent Fluid Selection : Calculate corrected serum sodium: Corrected N a + = Measured N a + + 0.3 × ( Glucose − 5.5 mmol/L ) \text{Corrected } Na^+ = \text{Measured } Na^+ + 0.3 \times (\text{Glucose} - 5.5 \text{ mmol/L}) Corrected N a + = Measured N a + + 0.3 × ( Glucose − 5.5 mmol/L )

If corrected N a + Na^+ N a + is normal or elevated ( ≥ 135 mmol/L \ge 135 \text{ mmol/L} ≥ 135 mmol/L ): Switch to 0.45% Sodium Chloride (Half-Normal Saline) at 250 – 500 mL/hr 250–500 \text{ mL/hr} 250–500 mL/hr .

If corrected N a + Na^+ N a + is low ( < 135 mmol/L < 135 \text{ mmol/L} < 135 mmol/L ): Continue 0.9% Sodium Chloride at 250 – 500 mL/hr 250–500 \text{ mL/hr} 250–500 mL/hr .

Addition of Dextrose (Preventing Cerebral Edema) :

In DKA : When CBG reaches 14.0 mmol/L 14.0 \text{ mmol/L} 14.0 mmol/L , add 5% Dextrose in 0.45% NaCl (or 5% Dextrose in 0.9% NaCl) and reduce the continuous IV insulin infusion rate to 0.02 – 0.05 units/kg/hr 0.02–0.05 \text{ units/kg/hr} 0.02–0.05 units/kg/hr .

In HHS : When CBG reaches 16.7 mmol/L 16.7 \text{ mmol/L} 16.7 mmol/L , add 5% Dextrose to IV hydration fluids.

Rationale : Maintaining CBG between 10.0 and 14.0 mmol/L in DKA (13.9–16.7 mmol/L in HHS) while continuing insulin suppresses lipolysis and ketogenesis while avoiding rapid drops in plasma osmolality that trigger osmotic shift into brain parenchymal cells, causing fatal cerebral edema .

  • Continuous Insulin Therapy & Potassium Safety Guidelines
  • Potassium Safety Threshold (MOH & SNB Critical Standard)

Insulin causes an intracellular shift of glucose and potassium by activating the N a + / K + Na^+/K^+ N a + / K + -ATPase pump. Administering IV insulin in the presence of hypokalemia leads to precipitous drops in serum potassium, triggering lethal ventricular dysrhythmias and respiratory muscle paralysis.

Serum K + < 3.5 mmol/L K^+ < 3.5 \text{ mmol/L} K + < 3.5 mmol/L : HOLD IV INSULIN INFUSION IMMEDIATELY . Administer IV Potassium Chloride (KCl) at 20 – 30 mEq/hr 20–30 \text{ mEq/hr} 20–30 mEq/hr (via central line or dedicated infusion pump under continuous telemetry) until serum K + ≥ 3.5 mmol/L K^+ \ge 3.5 \text{ mmol/L} K + ≥ 3.5 mmol/L .

Serum K + K^+ K + 3.5 – 5.2 mmol/L : Initiate or continue IV insulin infusion. Add 20 – 30 mEq 20–30 \text{ mEq} 20–30 mEq KCl per liter of IV infusion fluid to maintain serum potassium between 4.0 and 5.0 mmol/L 4.0 \text{ and } 5.0 \text{ mmol/L} 4.0 and 5.0 mmol/L .

Serum K + > 5.2 mmol/L K^+ > 5.2 \text{ mmol/L} K + > 5.2 mmol/L : Initiate IV insulin infusion. Do not add KCl to IV fluids. Monitor serum potassium every 2 hours until levels fall below 5.2 mmol/L 5.2 \text{ mmol/L} 5.2 mmol/L .

Insulin Infusion Protocol

Bolus vs Continuous : Current guidelines recommend continuous fixed-rate IV Regular Insulin infusion at 0.1 units/kg/hr 0.1 \text{ units/kg/hr} 0.1 units/kg/hr (e.g., 7 units/hr for a 70 kg adult). An initial IV bolus ( 0.1 units/kg 0.1 \text{ units/kg} 0.1 units/kg ) is optional.

Target Rate of Glucose Reduction : Capillary blood glucose should decrease at a steady rate of 3.0 to 5.0 mmol/L per hour 3.0 \text{ to } 5.0 \text{ mmol/L per hour} 3.0 to 5.0 mmol/L per hour . If glucose fails to decline by 3.0 mmol/L 3.0 \text{ mmol/L} 3.0 mmol/L in the first hour, verify IV line patency, infusion pump settings, and double the insulin infusion rate.

Sodium Bicarbonate Indications

Sodium bicarbonate administration is not recommended for routine DKA resuscitation. It is indicated only when initial arterial pH < 6.90 \text{pH} < 6.90 pH < 6.90 .

Risks of Bicarbonate Therapy : Paradoxical central nervous system acidosis (due to rapid diffusion of C O 2 CO_2 C O 2 ​ across the blood-brain barrier), severe hypokalemia, delayed ketone clearance, and tissue hypoxia (left-shift of oxyhemoglobin dissociation curve).

DKA Resolution Criteria & Subcutaneous Transition Protocol

DKA is considered resolved when all of the following laboratory criteria are met:

Capillary Blood Glucose < 11.1 mmol/L < 11.1 \text{ mmol/L} < 11.1 mmol/L .

Serum Bicarbonate ≥ 18 mEq/L \ge 18 \text{ mEq/L} ≥ 18 mEq/L .

Venous Blood pH > 7.30 \text{pH} > 7.30 pH > 7.30 .

Normal Anion Gap ( ≤ 12 mEq/L \le 12 \text{ mEq/L} ≤ 12 mEq/L ).

Subcutaneous Insulin Transition Protocol

To prevent rebound hyperglycemia and recurrent ketoacidosis, never abruptly discontinue the IV insulin infusion .

Basal Subcutaneous Overlap : Administer long-acting subcutaneous basal insulin (e.g., Insulin Glargine or Degludec) 1 to 2 hours prior to stopping the IV insulin infusion .

Timing : Schedule the transition to coincide with a mealtime when the patient is alert, non-nauseated, and able to eat oral food.

  • Critical Nursing Complications & Clinical Scenario
  • Cerebral Edema Vigilance

Cerebral edema is a devastating complication occurring primarily in children and young adults during DKA treatment, caused by rapid osmolality reduction.

Warning Signs : Severe headache, lethargy, confusion, bradycardia, hypertension (Cushing's triad), incontinence, and papilledema.

Immediate Nursing Actions : Elevate head of bed to 30 ∘ 30^\circ 3 0 ∘ , immediately notify physician, slow IV infusion rate, and administer IV Mannitol 0.5 – 1.0 g/kg 0.5–1.0 \text{ g/kg} 0.5–1.0 g/kg or 3% Hypertonic Saline as ordered.

Clinical Nursing Scenario

Scenario : A 22-year-old female university student with T1DM presents to the Emergency Department with a 2-day history of fever, nausea, vomiting, and abdominal pain. On arrival: GCS 14 (drowsy), BP 92/58 mmHg, HR 128 bpm, RR 32 breaths/min (deep, rapid Kussmaul breathing with sweet fruity breath odor). STAT bloods: CBG 26.4 mmol/L 26.4 \text{ mmol/L} 26.4 mmol/L , Venous pH 7.12 \text{pH } 7.12 pH 7.12 , H C O 3 − 9.2 mEq/L HCO_3^- \text{ 9.2 mEq/L} H C O 3 − ​ 9.2 mEq/L , Serum K + 3.1 mmol/L K^+ \text{ 3.1 mmol/L} K + 3.1 mmol/L , Anion Gap 22 mEq/L 22 \text{ mEq/L} 22 mEq/L . Nursing Action : Recognizing severe DKA with critical hypokalemia ( K + < 3.5 mmol/L K^+ < 3.5 \text{ mmol/L} K + < 3.5 mmol/L ), the RN immediately initiates IV 0.9% Normal Saline at 1000 mL/hr 1000 \text{ mL/hr} 1000 mL/hr but withholds the ordered IV insulin infusion . The RN alerts the medical officer, inserts a dedicated IV line for potassium replacement, and infuses IV KCl at 20 mEq/hr 20 \text{ mEq/hr} 20 mEq/hr . After 2 hours, repeat serum K + K^+ K + is 3.8 mmol/L 3.8 \text{ mmol/L} 3.8 mmol/L . The RN then safely commences continuous IV Regular Insulin at 0.1 units/kg/hr 0.1 \text{ units/kg/hr} 0.1 units/kg/hr while adding 20 mEq 20 \text{ mEq} 20 mEq KCl per liter of IV maintenance fluid, conducting hourly CBG and neurological observations.

Loading diagram... DKA / HHS Resuscitation & Potassium Protocol Flowchart

Fluid Deficit Comparison: DKA vs HHS (Liters)